Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC35190 7-Ethylcamptothecin

    7-乙基喜树碱

    An anticancer agent
  3. GC35184 7,3',4'-Tri-O-methylluteolin

    木犀草素-7,3',4'-三甲醚; 5-Hydroxy-3',4',7-trimethoxyflavone

    7,3',4'-Tri-O-methylluteolin (5-Hydroxy-3',4',7-trimethoxyflavone) 是一种来自草药马鞭草科 (Lippia nodiflora L.) 的类黄酮,Lippia nodiflora L. 已被证明具有抗炎,解热,镇咳,抗糖尿病,抗癌和抗黑素生成特性。7,3',4'-Tri-O-methylluteolin 以浓度依赖方式明显抑制促炎细胞因子,如 TNF-α,IL-6 和 IL-1β。7,3',4'-Tri-O-methylluteolin 显著降低在转录水平的诱导型一氧化氮合酶和环加氧酶-2 的 mRNA 表达。
  4. GC35150 5,7,4'-Trimethoxyflavone

    5,7,4'-三甲氧基黄酮

    4',5,7-Trimethoxyflavone (5,7,4'-Trimethoxyflavone, TMF) is a flavonoid isolated from Kaempferia parviflora (KP) that induces apoptosis. 4',5,7-Trimethoxyflavone increases sub-G1 phase, DNA fragmentation, annexin-V/PI staining and Bax/Bcl-xL ratio, activates caspase-3 and degrades poly (ADP-ribose) polymerase (PARP) protein.
  5. GC35147 5-(N,N-Hexamethylene)-amiloride

    阿米洛利,Hexamethylene amiloride; HMA

    An amiloride derivative with diverse biological activities
  6. GC35138 4-Methyldaphnetin

    4-甲基瑞香素

    7,8-Dihydroxy-4-methylcoumarin (DHMC) is a precursor in the synthesis of derivatives of 4-methyl coumarin, which has excellent radical scavenging properties.
  7. GC35112 3'-Hydroxypterostilbene

    3’-羟基紫檀茋

    3'-Hydroxypterostilbene (3'-HPT) is one of the active constituents of Sphaerophysa salsula and Pterocarpus marsupium which may be useful in treating different types of haematological malignancies. 3'-Hydroxypterostilbene, a natural pterostilbene analogue, effectively inhibits the growth of human colon cancer cells (IC50s of 9.0, 40.2, and 70.9 ?M for COLO 205, HCT-116, and HT-29 cells, respectively) by inducing apoptosis and autophagy. 3'-Hydroxypterostilbene inhibits the PI3K/Akt/mTOR/p70S6K, and p38MAPK pathways and activates the ERK1/2, JNK1/2 MAPK pathways.
  8. GC35106 3-Dehydrotrametenolic acid

    3-氢化去氢松苓酸

    3-?Dehydrotrametenolic acid,分离于茯苓菌核,是一种乳酸脱氢酶 (LDH) 抑制剂。3-?Dehydrotrametenolic acid 促进体外脂肪细胞分化,在体内起胰岛素增敏剂的作用。3-?Dehydrotrametenolic acid 诱导细胞凋亡,具有抗癌活性。
  9. GC35099 3-O-Acetyloleanolic acid

    齐墩果酸3-乙酸酯

    A triterpene with diverse biological activities
  10. GC35057 14-Deoxyandrographolide

    14-去氧穿心莲内酯

    A diterpene lactone with diverse biological properties
  11. GC35013 [8]-Shogaol

    8-姜烯酚

    [8]-Shogaol,生姜中的一种刺激性酚类化合物,具有抗血小板活性 (IC50=5 μM) 和抑制 COX-2 (IC50=17.5 μM)。[8]-Shogaol 诱导人白血病细胞凋亡。
  12. GC35001 (S)-Gossypol acetic acid

    (S)-(+)-Gossypol acetic acid

    (S)-Gossypol acetic acid 是天然产物 Gossypol 的异构体。(S)-Gossypol 以高亲和力结合到 Bcl-xL 和 Bcl-2 蛋白的 BH3 结合沟。
  13. GC34981 (E)-Flavokawain A

    卡瓦胡椒素A

    A chalcone with diverse biological activities
  14. GC34980 (E)-Ferulic acid

    反式阿魏酸,(E)-Coniferic acid

    Trans-ferulic acid is a potent activator of AMPKunder high glucose condition.
  15. GC34965 (20S)-Protopanaxatriol

    20 (S)-原人参三醇; 20(S)-APPT; g-PPT

    An active ginsenoside metabolite
  16. GC15291 GSK3145095 GSK3145095 是一种 RIP1 激酶抑制剂,IC50 为 6.3 nM。
  17. GC45270 (±)10(11)-EDP Ethanolamide

    10,11-EDP-EA, 10,11-EDP epoxide, 10,11-epoxy Docosapentaenoic Ethanolamide

    An ω-3 endocannabinoid epoxide and CB receptor agonist
  18. GC45265 (+)-Goniothalesdiol A natural product with cytotoxic activity
  19. GC45256 (+)-ar-Turmerone

    (6S)-2-甲基-6-(4-甲基苯基)-2-庚烯-4-酮,(+)-ar-Turmerone

    A natural compound with immunomodulatory activities
  20. GC45246 (-)-Chaetominine

    (-)-Chaetominine

    A cytotoxic alkaloid
  21. GC45244 (-)-(α)-Kainic Acid (hydrate)

    红藻氨酸

    An L-glutamate analog with neuroexcitatory activities

  22. GC45213 α-NETA

    2-(BETA-萘甲酰基)乙基三甲基碘化铵

    An inhibitor of choline acetyltransferase
  23. GC45204 α-Ecdysone

    蜕皮激素; α-Ecdysone

    蜕皮激素(α-蜕皮激素)是一种存在于昆虫和植物中的类固醇蜕皮激素,可激活盐皮质激素受体(MR),从而导致肾小球疾病。

  24. GC45193 Z-YVAD-CMK (trifluoroacetate salt)

    Benxyloxycarbonyl-Tyr-Val-Ala-Asp-Chloromethylketone, Caspase-1 Inhibitor IV

    An inhibitor of caspase-1 and caspase-3
  25. GC45191 Z-VDVAD-pNA (trifluoroacetate salt)

    Z-VDVAD-p-nitroanilide, Z-Val-Asp-Val-Ala-Asp-pNA, Z-Val-Asp-Val-Ala-Asp-p-nitroanilide

    A colorimetric caspase-2 substrate
  26. GC45190 Z-VDVAD-AFC (trifluoroacetate salt)

    Z-Val-Asp-Val-Ala-Asp-AFC, Z-Val-Asp-Val-Ala-Asp-7-amino-4-trifluormethylcoumarin

    A fluorogenic substrate for caspase-2
  27. GC45189 Z-VAD(OH)-FMK

    Z-VAD(OH)-FMK

    Z-VAD(OH)-FMK是所有半胱天冬酶的不可逆三肽抑制剂。
  28. GC45181 Z-IETD-AFC

    Z-异亮氨酰-谷氨酰-苏氨酰-天冬氨酸-AFC

    A fluorogenic substrate for caspase-8 and granzyme B
  29. GC45178 Z-DEVD-CMK (trifluoroacetate salt)

    Z-Asp-Glu-Val-Asp-CMK

    An irreversible protease inhibitor
  30. GC45177 Z-AEVD-FMK

    Z-Ala-Glu-Val-Asp-Fluoromethyl Ketone

    A caspase-10 inhibitor
  31. GC45175 YVAD-CHO (trifluoroacetate salt)

    H-Tyr-Val-Ala-Asp-CHO

    A caspase-1/ICE inhibitor
  32. GC45149 VK3-OCH3

    Vitamin K3-OCH3

    An analog of vitamin K3
  33. GC45132 Ursodeoxycholic Acid (sodium salt)

    熊去氧胆酸钠盐; Ursodeoxycholate sodium; Ursodiol sodium; UCDA sodium

    A secondary bile acid
  34. GC45090 Triparanol

    曲帕拉醇,MER-29

    An inhibitor of DHCR24
  35. GC45066 Tosyl Phenylalanyl Chloromethyl Ketone

    L-1,4'-甲基磺酰基-2-苯基乙基氯甲基酮,L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK

    An inhibitor of chymotrypsin-like serine proteases
  36. GC45039 Thiocolchicine

    硫代秋水仙碱

    An inhibitor of microtubule assembly
  37. GC45031 Thiamine (hydrochloride)

    Aneurine, Vitamin B1

    Thiamine is a water-soluble vitamin with antioxidant, neuroprotective, and anxiolytic properties.
  38. GC45014 Termitomycamide B A fatty acid amide that protects against ER stress-dependent cell death
  39. GC44992 Taurochenodeoxycholic Acid (sodium salt)

    牛磺鹅去氧胆酸钠盐; 12-Deoxycholyltaurine sodium

    A taurine-conjugated form of chenodeoxycholic acid
  40. GC44989 TAN 420E

    Dihydroherbimycin A

    A bacterial metabolite
  41. GC44981 T-2 Toxin

    T-2毒素(镰刀菌属),T-2 Mycotoxin

    A trichothecene mycotoxin
  42. GC44973 Sultriecin

    BU-3285T, Phostriecin

    A fungal metabolite
  43. GC44967 Suc-YVAD-AMC (acetate)

    Suc-Tyr-Val-Ala-Asp-AMC, Suc-Tyr-Val-Ala-Asp-7-amino-4-methylcoumarin, Suc-YVAD-NH-Mec

    A fluorogenic substrate for caspase-1
  44. GC44956 Streptochlorin

    3-(4-氯-5-恶唑基)-1H-吲哚

    A bacterial metabolite with diverse biological activities
  45. GC44953 Sterigmatocystin

    甾体半胱氨酸

    甾体半胱氨酸是由曲霉属真菌产生的一种霉菌毒素。
  46. GC44943 sPLA2 Inhibitor

    KH064, Secretory Phospholipase A2 Inhibitor

    An orally active inhibitor of sPLA2-IIA
  47. GC44899 SLF

    Synthetic Ligand of FKBP

    A synthetic FK-506 Binding Protein (FKBP) ligand
  48. GC44897 SL 01

    N-苯氧基碳-L-苯丙氨酰甲基氯酮,SL-01

    An inhibitor of SARS-CoV Mpro
  49. GC44896 SKI 178 A non-selective inhibitor of SPHK1 and SPHK2
  50. GC44892 Siomycin A

    盐霉素 A

    An inhibitor of FoxM1
  51. GC44888 SI-2

    EPH 116

    An inhibitor of SRC-3

Items 1401 to 1450 of 2733 total

per page

Set Descending Direction